Teva Pharmaceutical Industries News

Might be time to buy calls of Teva Pharmaceutical, the world's leading generic-drug maker.

SCI Corporation announced today that it has entered into an exclusive licensing agreement with Teva Pharmaceutical Industries Ltd.

A recent cross-border merger met some thorny IRS requirements including passing the Helen of Troy test to capture tax-free status as a reorganization.

What have been the best stocks to own in this new millennium, by all accounts the most Britney-filled of all the millennia on record so far? And what, if anything, can we learn by simply running a couple of ...

LONDON : European stocks rose Friday, led by consumer-goods companies, as falling commodity prices eased concern that inflation would force central banks to lift interest rates.

Well, the market was in the dumps yesterday and is even worse today. So this may be a good time to check on my list of stocks for those looking for equities that are stable enough to ride out this bearish ...

Shares of Par Pharmaceutical plunged today after the generic drug developer reported a second-quarter loss and slashed its outlook because of tougher competition and pricing pressure.

There are some 24 million Americans afflicted with diabetes, according to the American Diabetes Association, and it's estimated an additional 1 million cases are reported each year at a cost to public health of ...

Gary Gordon, author of the ETF Expert blog, highlights an eclectic mix of exchange-traded funds that have posted gains so far this year despite the down market: 1. iShares Biotechnology Fund .

Wyeth received additional subpoenas from a U.S. grand jury in Massachusetts investigating the marketing and pricing of the heartburn drug Protonix.

Israeli stocks closed mixed on Tuesday as investors chewed over Teva's earnings report and the Bank of Israel's third straight quarter-point rate increase.

The Israeli generic drugmaker posted net income of $539 million, or 65 cents a share, compared with $515 million, or 63 cents.

Market's mixed; Teva beats estimate and shares drop - MarketWatch Intraday data provided by Interactive Data Real Time Services , a division of Interactive Data Corp.

For the quarter, TEVA reported net income of $539 million, or 65 cents per share, compared with $515 million, or 63 cents, last year.

Israeli stocks finished higher Wednesday, with Teva Pharmaceutical and a handful of tech companies getting good analyst reviews, Alvarion Ltd.

Antares Pharma, Inc. , a specialty pharmaceutical company focused on improving pharmaceuticals through advanced drug delivery systems, and its partner, Teva Pharmaceutical Industries Ltd.

Antares Pharma, Inc. , a specialty pharmaceutical company focused on improving pharmaceuticals through advanced drug delivery systems, and its partner, Teva Pharmaceutical Industries Ltd.

Antares Pharma, Inc. , a specialty pharmaceutical company focused on improving pharmaceuticals through advanced drug delivery systems, and its partner, Teva Pharmaceutical Industries Ltd.

Antares Pharma, Inc. , a specialty pharmaceutical company focused on improving pharmaceuticals through advanced drug delivery systems, and its partner, Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended June 30, 2008.